1. Home
  2. SBET vs NVAX Comparison

SBET vs NVAX Comparison

Compare SBET & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SharpLink Gaming Ltd.

SBET

SharpLink Gaming Ltd.

N/A

Current Price

$5.99

Market Cap

1.5B

Sector

Technology

ML Signal

N/A

Logo Novavax Inc.

NVAX

Novavax Inc.

N/A

Current Price

$9.15

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SBET
NVAX
Founded
1995
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2025
1996

Fundamental Metrics

Financial Performance
Metric
SBET
NVAX
Price
$5.99
$9.15
Analyst Decision
Strong Buy
Hold
Analyst Count
7
9
Target Price
$18.71
$11.33
AVG Volume (30 Days)
7.0M
4.7M
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
309.76
EPS
N/A
N/A
Revenue
$28,055,000.00
$1,123,479,000.00
Revenue This Year
$105.19
N/A
Revenue Next Year
$13.53
N/A
P/E Ratio
N/A
N/A
Revenue Growth
666.04
64.69
52 Week Low
$5.06
$6.20
52 Week High
$40.46
$11.85

Technical Indicators

Market Signals
Indicator
SBET
NVAX
Relative Strength Index (RSI) 47.81 48.14
Support Level $5.06 $8.89
Resistance Level $8.20 $10.67
Average True Range (ATR) 0.36 0.65
MACD 0.02 -0.16
Stochastic Oscillator 70.08 24.84

Price Performance

Historical Comparison
SBET
NVAX

About SBET SharpLink Gaming Ltd.

SharpLink Inc is one of those publicly traded companies to adopt ETH as its primary treasury reserve asset. This move reflects the Company's commitment to align corporate treasury with the future of programmable finance, digital capital markets, and decentralized infrastructure. The Company also operates an online affiliate marketing company that delivers different fan activation solutions to its sportsbook and online casino gaming partners. The company operates in two reportable segments: ETH Treasury Management and Affiliate Marketing. The majority of its revenue is generated from the ETH Treasury Management. Geographically, the company operates in the United States and the rest of the world.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: